JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB1432

HDAC Activity Assay Kit (colorimetric)

Be the first to review this product! Submit a review

|

(57 Publications)

HDAC Activity Assay Kit (Colorimetric) ab1432 uses an acetylated lysine peptide substrate to measure HDAC activity.

View Alternative Names

RPD3L1, HDAC1, Histone deacetylase 1, HD1, Protein deacetylase HDAC1, Protein deacylase HDAC1

2 Images
Enzyme activity assay - HDAC Activity Assay Kit (colorimetric) (AB1432)
  • Enzyme activity assay

Supplier Data

Enzyme activity assay - HDAC Activity Assay Kit (colorimetric) (AB1432)

HDAC Activity Colorimetric Assay Kit Activity Assay.

Different amount of nuclear extract (NE) were tested following kit protocol in the presence and absence of HDAC Inhibitor (Incubated for 4 hrs).

Enzyme activity assay - HDAC Activity Assay Kit (colorimetric) (AB1432)
  • Enzyme activity assay

Supplier Data

Enzyme activity assay - HDAC Activity Assay Kit (colorimetric) (AB1432)

HDAC Activity Colorimetric Assay Kit Standard Curve

Key facts

Detection method

Colorimetric

Sample types

Nuclear Extracts, Cell Lysate

Assay type

Quantitative

Assay Platform

Microplate (12 x 8 well strips)

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "Enzyme activity assay": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

HDAC Activity Assay Kit (Colorimetric) ab1432 provides a fast and convenient colorimetric method that eliminates radioactivity, extractions, or chromatography, as used in the traditional assays. The new method requires only two easy steps, both performed on the same microtiter plate. First, the HDAC colorimetric substrate, which comprises an acetylated lysine side chain, is incubated with a sample containing HDAC activity (e.g., HeLa nuclear extract or your own samples). Deacetylation of the substrate sensitizes the substrate, so that, in the second step, treatment with the Lysine Developer produces a chromophore. The chromophore can be easily analyzed using an ELISA plate reader or spectrophotometer. The assay is well suited for high throughput screening applications.

Inhibition of histone deacetylases (HDACs) has been implicated in the modulation of transcription and the induction of apoptosis or differentiation in cancer cells. However, screening HDAC inhibitory compounds has proven to be difficult over the past due to the lack of convenient tools for analyzing HDAC activity.

Other Notes
This product was previously called K331 HDAC Activity Colorimetric Assay Kit. Biovision was acquired by Abcam in 2021.

Read the entire protocol (attached to the datasheet) before beginning the procedure.

The HeLa extract should be refrozen immediately at -20 or -70°C after each use to avoid loss of activity. The Lysine Developer should be refrozen immediately at -20 or -70°C after each use or aliquotted for future use.

This kit contains enough reagents for about 100 tests. If positive and negative controls are included, the kit provides sufficient reagents for 5 positive control assays with the HeLa Nuclear Extract and 5 Negative Control assays with the HDAC Inhibitor, Trichostatin A.

The Safety Datasheet for this product has been updated for certain countries. Please check the current version in the Support and downloads section.

What's included?

{ "values": { "96Test": { "sellingSize": "96 Test", "publicAssetCode":"ab1432-96Test", "assetComponentDetails": [ { "size":"1 x 50 µL", "name":"HeLa Nuclear Extract", "number":"AB1432-CMP05", "productcode":"" }, { "size":"1 x 500 µL", "name":"HDAC Substrate I", "number":"AB1432-CMP04", "productcode":"" }, { "size":"1 x 1 mL", "name":"Developer Mix M", "number":"AB1432-CMP06", "productcode":"" }, { "size":"1 x 20 µL", "name":"Deacetylated Standard (10 mM)", "number":"AB1432-CMP02", "productcode":"" }, { "size":"1 x 1 mL", "name":"10X Assay Buffer 30", "number":"AB1432-CMP01", "productcode":"" }, { "size":"1 x 10 µL", "name":"HDAC Inhibitor", "number":"AB1432-CMP03", "productcode":"" } ] } } }

Properties and storage information

Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-80°C
Appropriate long-term storage conditions
-80°C
Storage information
-80°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Histone deacetylases commonly known as HDACs are enzymes that remove acetyl groups from histone proteins resulting in chromatin tightening and reduced gene transcription. These enzymes fall into several classes each with distinct structural features and typically have molecular masses ranging from 41 to 70 kDa. HDACs are expressed in various tissues including brain heart and muscle. HDAC activity is essential for the regulation of many cellular processes and can be measured using assays such as the HDAC activity assay or the colorimetric assay.
Biological function summary

HDACs play an important role in gene expression through the remodeling of chromatin structure. They are often part of multiprotein complexes with co-repressor proteins helping modulate the transcription of genes involved in cell cycle regulation and differentiation. This modulation impacts cellular activities such as proliferation and apoptosis making HDACs significant in normal cellular function and development. HDAC inhibitors serve as tools for research in studying HDAC functions and as potential therapeutic agents.

Pathways

HDACs influence the regulation of important cellular pathways like the cell cycle and apoptosis. They interact with other proteins such as histone deacetylase inhibitor proteins and transcription factors to regulate gene expression tightly. In the cell cycle pathway HDACs can repress the transcription of cyclin-dependent kinase inhibitors therefore promoting cell cycle progression. Their involvement in the apoptosis pathway is also important where they regulate pro-apoptotic and anti-apoptotic gene expression contributing to cellular homeostasis.

HDACs have a significant connection to cancer and neurological disorders. Overexpression or dysregulation of HDACs can lead to tumorigenesis by affecting cell cycle checkpoints and apoptotic pathways. HDAC inhibitors have been investigated as potential cancer therapies targeting cellular proliferation and survival mechanisms. In neurological disorders HDACs are associated with neurodegenerative diseases due to their role in neuronal gene expression regulation. Proteins such as the tumor suppressor p53 in cancer and tau proteins in Alzheimer's disease have connections to HDAC function linking these enzymes to pathological processes.

Product protocols

Target data

Histone deacetylase that catalyzes the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4) (PubMed : 16762839, PubMed : 17704056, PubMed : 28497810). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events (PubMed : 16762839, PubMed : 17704056). Histone deacetylases act via the formation of large multiprotein complexes (PubMed : 16762839, PubMed : 17704056). Acts as a component of the histone deacetylase NuRD complex which participates in the remodeling of chromatin (PubMed : 16428440, PubMed : 28977666). As part of the SIN3B complex is recruited downstream of the constitutively active genes transcriptional start sites through interaction with histones and mitigates histone acetylation and RNA polymerase II progression within transcribed regions contributing to the regulation of transcription (PubMed : 21041482). Also functions as a deacetylase for non-histone targets, such as NR1D2, RELA, SP1, SP3, STAT3 and TSHZ3 (PubMed : 12837748, PubMed : 16285960, PubMed : 16478997, PubMed : 17996965, PubMed : 19343227). Deacetylates SP proteins, SP1 and SP3, and regulates their function (PubMed : 12837748, PubMed : 16478997). Component of the BRG1-RB1-HDAC1 complex, which negatively regulates the CREST-mediated transcription in resting neurons (PubMed : 19081374). Upon calcium stimulation, HDAC1 is released from the complex and CREBBP is recruited, which facilitates transcriptional activation (PubMed : 19081374). Deacetylates TSHZ3 and regulates its transcriptional repressor activity (PubMed : 19343227). Deacetylates 'Lys-310' in RELA and thereby inhibits the transcriptional activity of NF-kappa-B (PubMed : 17000776). Deacetylates NR1D2 and abrogates the effect of KAT5-mediated relieving of NR1D2 transcription repression activity (PubMed : 17996965). Component of a RCOR/GFI/KDM1A/HDAC complex that suppresses, via histone deacetylase (HDAC) recruitment, a number of genes implicated in multilineage blood cell development (By similarity). Involved in CIART-mediated transcriptional repression of the circadian transcriptional activator : CLOCK-BMAL1 heterodimer (By similarity). Required for the transcriptional repression of circadian target genes, such as PER1, mediated by the large PER complex or CRY1 through histone deacetylation (By similarity). In addition to protein deacetylase activity, also has protein-lysine deacylase activity : acts as a protein decrotonylase and delactylase by mediating decrotonylation ((2E)-butenoyl) and delactylation (lactoyl) of histones, respectively (PubMed : 28497810, PubMed : 35044827).
See full target information HDAC1

Publications (57)

Recent publications for all applications. Explore the full list and refine your search

Clinical epigenetics 16:109 PubMed39155390

2024

HDAC6 inhibition disrupts HDAC6-P300 interaction reshaping the cancer chromatin landscape.

Applications

Unspecified application

Species

Unspecified reactive species

Michela Gottardi Zamperla,Barbara Illi,Veronica Barbi,Chiara Cencioni,Daniele Santoni,Stella Gagliardi,Maria Garofalo,Gabriele Antonio Zingale,Irene Pandino,Diego Sbardella,Lina Cipolla,Simone Sabbioneda,Antonella Farsetti,Chiara Ripamonti,Gianluca Fossati,Christian Steinkühler,Carlo Gaetano,Sandra Atlante

Scientifica 2023:6360487 PubMed37885471

2023

The Histone Deacetylase Inhibitory Potential of Chicken Egg Yolk Fat and Their Fatty Acid Composition.

Applications

Unspecified application

Species

Unspecified reactive species

Meran Keshawa Ediriweera

EBioMedicine 76:103838 PubMed35148983

2022

Probiotics counteract hepatic steatosis caused by ketogenic diet and upregulate AMPK signaling in a model of infantile epilepsy.

Applications

Unspecified application

Species

Unspecified reactive species

Chunlong Mu,Naghmeh Nikpoor,Thomas A Tompkins,Jong M Rho,Morris H Scantlebury,Jane Shearer

Experimental and therapeutic medicine 21:359 PubMed33732332

2021

MicroRNA-874-3p promotes testosterone-induced granulosa cell apoptosis by suppressing HDAC1-mediated p53 deacetylation.

Applications

Unspecified application

Species

Unspecified reactive species

Youhua Wei,Zhijun Wang,Li Wei,Shen Li,Xuemei Qiu,Chengwen Liu

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 54:1143-1162 PubMed33201644

2020

Histone Deacetylase Activity and the Renin-Angiotensin-Aldosterone System: Key Elements in Cardiorenal Alterations Provoked by Chronic Malnutrition in Male Adult Rats.

Applications

Unspecified application

Species

Unspecified reactive species

Humberto Muzi-Filho,Larissa B Jannuzzi,Ana C S Bouzan,Sarana Alves-Barros,Danilo S Alves-Bezerra,Amaury Pereira-Acácio,Bruna S N Ferreira,Debora Silva-Pereira,Gloria Costa-Sarmento,Adalberto Vieyra

Biotechnology reports (Amsterdam, Netherlands) 28:e00531 PubMed33014717

2020

Osthole extracted from a citrus fruit that affects apoptosis on A549 cell line by histone deacetylasese inhibition (HDACs).

Applications

Unspecified application

Species

Unspecified reactive species

Hamed A Abosharaf,Thoria Diab,Faten M Atlam,Tarek M Mohamed

Molecular therapy. Nucleic acids 22:222-235 PubMed33230429

2020

EpCAM-Targeted 3WJ RNA Nanoparticle Harboring Delta-5-Desaturase siRNA Inhibited Lung Tumor Formation via DGLA Peroxidation.

Applications

Unspecified application

Species

Unspecified reactive species

Lizhi Pang,Harshit Shah,Hongzhi Wang,Dan Shu,Steven Y Qian,Venkatachalem Sathish

International journal of environmental research and public health 17: PubMed32492926

2020

Environmental Stimulation Counteracts the Suppressive Effects of Maternal High-Fructose Diet on Cell Proliferation and Neuronal Differentiation in the Dentate Gyrus of Adult Female Offspring via Histone Deacetylase 4.

Applications

Unspecified application

Species

Unspecified reactive species

Wen-Chung Liu,Chih-Wei Wu,Pi-Lien Hung,Julie Y H Chan,You-Lin Tain,Mu-Hui Fu,Lee-Wei Chen,Chih-Kuang Liang,Chun-Ying Hung,Hong-Ren Yu,I-Chun Chen,Kay L H Wu

Adipocyte 9:120-131 PubMed32163011

2020

Low and high concentrations of butyrate regulate fat accumulation in chicken adipocytes via different mechanisms.

Applications

Unspecified application

Species

Unspecified reactive species

Liqin Zhao,Shuang Liu,Zhihao Zhang,Jianmei Zhang,Xiaoqian Jin,Jing Zhang,Wenxiang Jiang,Haifang Li,Hai Lin

World journal of gastroenterology 26:598-613 PubMed32103870

2020

Histone deacetylase inhibitor pre-treatment enhances the efficacy of DNA-interacting chemotherapeutic drugs in gastric cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Ramchandra Vigay Amnekar,Shafqat Ali Khan,Mudasir Rashid,Bharat Khade,Rahul Thorat,Poonam Gera,Shailesh V Shrikhande,Duane T Smoot,Hassan Ashktorab,Sanjay Gupta
View all publications
websiteProtocolBooklet
en

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com